Among patients undergoing total knee arthroplasty, aspirin alone may provide protection against postoperative venous thromboembolism that is similar to that of other anticoagulants.
Continuous or extended combined oral contraceptive regimens not linked to higher venous thromboembolism riskOctober 11, 2018
In this retrospective cohort study, continuous (84/7) or extended (365/0) cycle regimens of combined oral contraceptives were not linked with meaningfully higher rates of venous thromboembolism when compared with traditional cyclic (21/7) regimens.
At 6 months, rates for provoked, unprovoked, cancer-related VTE are 6.8, 6.92, 9.06 per 100 person-years.
Mendelian randomization analysis provides evidence that increased height causally tied to varicose veins.
Incidence of major bleeding low with rivaroxaban, but clot risk not lower.
Migraines are linked to cardiovascular events, including myocardial infarction, VTE, and stroke.
Increased frequency of television viewing may be linked to an increased risk for venous thromboembolism.
The addition of pharmacomechanical thrombolysis does not reduce the risk of post-thrombotic syndrome among patients with acute proximal deep vein thrombosis.
Compared with warfarin, treatment with DOACs was not associated with an increased risk of major bleeding or all-cause mortality within the first 90 days.
In the 1 to 10 days after flu vaccine administration, there was no increased risk for VTE.
The researchers found that concurrent use of amiodarone, fluconazole, rifampin, and phenytoin was associated with increased risk of major bleeding compared with the use of NOACs alone.
VTE and cancer are the result of inflammation and immunological dysfunctions associated with RA.
Researchers found a strong association between VTE and height using sibling pair analysis.
Researchers observed a linear increase in cancer prevalence with age, with a 7-fold higher prevalence in patients older than 50 years of age.
Fondaparinux and rivaroxaban were associated with increased risk of major bleeding in patients who underwent total hip or knee arthroplasty.
Researchers found a paradoxical increase in thromboembolism risk in low-weight patients with atrial fibrillation and VTE who were treated with direct oral anticoagulants.
Researchers developed a protocol to demonstrate the efficacy of rivaroxaban in lowering the risk of venous thromboembolism among orthopedic joint surgery patients.
The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.
Results showed that mean induction times, analyzed in 170 patients, were 12.87 days in the HIV-infected patients and 11.19 days in the HIV-uninfected patients.
Surgical pulmonary embolectomy for peripheral distribution of thrombus demonstrated positive outcomes in patients with either CPE or PPE.
Short-term oral corticosteroid use associated with increased risk for sepsis, venous thromboembolismApril 27, 2017
Approximately 1 in 5 American adults use corticosteroids in the short term, which is associated with an increased risk for sepsis, venous thromboembolism, and fracture.
Researchers sought to determine the risk of venous thromboembolism associated with use of testosterone treatment.
The reduction in thromboembolism was attenuated after accounting for competing death events.
In patients with first unprovoked venous thromboembolism, adding CT to limited cancer screening may not lead to statistically higher rate of cancer detectionFebruary 02, 2016
Unprovoked venous thromboembolism has been associated with the presence of occult malignancies.